Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,305,000 | 10,060,000 | 7,965,000 | 5,427,000 | 2,839,000 |
| Depreciation Amortization | 521,000 | 2,093,000 | 1,586,000 | 1,063,000 | 515,000 |
| Income taxes - deferred | -153,000 | -235,000 | -552,000 | -212,000 | 53,000 |
| Accounts receivable | -572,000 | -599,000 | -670,000 | -893,000 | -617,000 |
| Other Working Capital | -389,000 | -1,021,000 | -1,121,000 | -2,253,000 | -907,000 |
| Other Operating Activity | 762,000 | 1,501,000 | 1,428,000 | 1,517,000 | 752,000 |
| Operating Cash Flow | $3,474,000 | $11,799,000 | $8,636,000 | $4,649,000 | $2,635,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -445,000 | -2,478,000 | -1,338,000 | -797,000 | -320,000 |
| Net Acquisitions | -811,000 | -987,000 | -747,000 | -693,000 | N/A |
| Purchase Of Investment | -327,000 | -5,660,000 | -5,095,000 | -4,999,000 | -3,824,000 |
| Sale Of Investment | 69,000 | 9,187,000 | 8,324,000 | 7,611,000 | 2,340,000 |
| Other Investing Activity | -63,000 | -341,000 | -295,000 | -282,000 | -210,000 |
| Investing Cash Flow | $-1,577,000 | $-279,000 | $849,000 | $840,000 | $-2,014,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 357,000 | 1,215,000 | 537,000 | 351,000 | 173,000 |
| Debt Issued | N/A | 6,000 | 4,000 | 4,000 | 4,000 |
| Debt Repayment | -7,000 | -196,000 | -196,000 | -20,000 | -17,000 |
| Common Stock Issued | 136,000 | 774,000 | 592,000 | 455,000 | 285,000 |
| Common Stock Repurchased | -401,000 | -1,717,000 | -1,164,000 | -988,000 | -654,000 |
| Dividend Paid | -982,000 | -3,793,000 | -2,810,000 | -1,829,000 | -847,000 |
| Other Financing Activity | -267,000 | -732,000 | -602,000 | -314,000 | -144,000 |
| Financing Cash Flow | $-1,164,000 | $-4,443,000 | $-3,639,000 | $-2,341,000 | $-1,200,000 |
| Exchange Rate Effect | 34,000 | -225,000 | -224,000 | -195,000 | -85,000 |
| Beginning Cash Position | 16,055,000 | 9,203,000 | 9,203,000 | 9,203,000 | 9,203,000 |
| End Cash Position | 16,822,000 | 16,055,000 | 14,825,000 | 12,156,000 | 8,539,000 |
| Net Cash Flow | $767,000 | $6,852,000 | $5,622,000 | $2,953,000 | $-664,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,474,000 | 11,799,000 | 8,636,000 | 4,649,000 | 2,635,000 |
| Capital Expenditure | -446,000 | -2,632,000 | -1,490,000 | -874,000 | -397,000 |
| Free Cash Flow | 3,028,000 | 9,167,000 | 7,146,000 | 3,775,000 | 2,238,000 |